Mean platelet volume in children with familial Mediterranean fever

被引:91
作者
Makay, Balahan [1 ]
Turkyilmaz, Zeynep [1 ]
Unsal, Erbil [1 ]
机构
[1] Dokuz Eylul Univ Hosp, Div Pediat Immunol & Rheumatol, Dept Pediat, TR-35340 Izmir, Turkey
关键词
Atherosclerosis; Children; Familial Mediterranean fever; Mean platelet volume; INTIMA-MEDIA THICKNESS; ATHEROSCLEROSIS; INTERLEUKIN-6; ACTIVATION; MARKERS;
D O I
10.1007/s10067-009-1148-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial Mediterranean fever (FMF) is the most common inherited periodic fever syndrome characterized by recurrent episodes of serositis. Recently, a few studies have suggested that FMF is related to increased risk of atherosclerosis. Mean platelet volume (MPV) is a marker of platelet activation. Larger platelets are associated with increased atherosclerosis risk. The aim of the study is to evaluate levels of MPV in pediatric FMF patients during and between attacks. The study consisted of 48 patients during an attack (group 1), 63 patients in attack-free period (at least 2 weeks after an attack, group 2), and 49 healthy controls (group 3). Erythrocyte sedimentation rate, C-reactive protein, white blood cell count, platelet count (PLT), and MPV levels were retrospectively recorded from the computerized patient database. Mean platelet volume was significantly lower in FMF patients during attack than in attack-free period (p = 0.00); however, there was no difference among attack-free patients and healthy controls (p = 0.38). The mean platelet counts of FMF patients during attack were higher than the healthy controls (p = 0.02). There was an inverse correlation between MPV and mean PLT in the attack-free period (r = -446, p = 0.01). This study suggests that an early atherosclerosis marker, MPV, is not elevated in pediatric FMF patients on colchicine treatment.
引用
收藏
页码:975 / 978
页数:4
相关论文
共 23 条
[1]   Are familial Mediterranean fever (IMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in IMF [J].
Akdogan, Ali ;
Calguneri, Meral ;
Yavuz, Bunyamin ;
Arslan, E. Bengi ;
Kalyoncu, Umut ;
Sahiner, Levent ;
Karadag, Omer ;
Ertenli, Ihsan ;
Kiraz, Sedat ;
Aytemir, Kudret ;
Akata, Deniz ;
Tokgozoglu, Lale ;
Oto, Ali .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (11) :2351-2353
[2]   Continuity of cytokine activation in patients with familial Mediterranean fever [J].
Bagci, S ;
Toy, B ;
Tuzun, A ;
Ates, Y ;
Aslan, M ;
Inal, A ;
Gulsen, M ;
Karaeren, N ;
Dagalp, K .
CLINICAL RHEUMATOLOGY, 2004, 23 (04) :333-337
[3]   Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients [J].
Baykal, Y ;
Saglam, K ;
Yilmaz, MI ;
Taslipinar, A ;
Akinci, SB ;
Inal, A .
CLINICAL RHEUMATOLOGY, 2003, 22 (02) :99-101
[4]   Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis [J].
Bilginer, Yelda ;
Ozaltin, Fatih ;
Basaran, Ceyla ;
Duzova, Ali ;
Besbas, Nesrin ;
Topaloglu, Rezan ;
Ozen, Seza ;
Bakkaloglu, Aysin .
RHEUMATOLOGY INTERNATIONAL, 2008, 28 (12) :1211-1216
[5]   Impaired coronary microvascular function in familial Mediterranean fever [J].
Caliskan, Mustafa ;
Gullu, Hakan ;
Yilmaz, Sema ;
Erdogan, Dogan ;
Unler, Gulhan Kanat ;
Ciftci, Ozgur ;
Topcu, Semra ;
Kayhan, Zeynep ;
Yucel, Eftal ;
Muderrisoglu, Haldun .
ATHEROSCLEROSIS, 2007, 195 (02) :E161-E167
[6]  
Cassidy JT, 2005, TXB PEDIAT RHEUMATOL, P657
[7]   Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood [J].
Clarke, D ;
Johnson, PWM ;
Banks, RE ;
Storr, M ;
Kinsey, SE ;
Johnson, R ;
Morgan, G ;
Gordon, MY ;
Illingworth, JM ;
Perren, TJ ;
Selby, PJ .
CYTOKINE, 1996, 8 (09) :717-723
[8]   Platelet activation in patients with Familial Mediterranean Fever [J].
Coban, Erkan ;
Adanir, H. .
PLATELETS, 2008, 19 (06) :405-408
[9]   Laboratory testing in the rheumatic diseases: A practical review [J].
Colglazier, CL ;
Sutej, PG .
SOUTHERN MEDICAL JOURNAL, 2005, 98 (02) :185-191
[10]  
Gang N, 1999, J RHEUMATOL, V26, P890